D&D Pharmatech디앤디파마텍
347850 · KOSDAQ · ₩347850 · 디앤디파마텍
₩40,850▼ ₩850 (2.04%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩4.3B | ₩11B |
| Operating income | −₩34B | −₩25B |
| Net income | −₩24B | −₩29B |
| Net income to shareholders | −₩24B | −₩29B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩98B | ₩97B |
| Current assets | ₩51B | ₩40B |
| Cash and equivalents | ₩33B | ₩30B |
| Total liabilities | ₩19B | ₩28B |
| Current liabilities | ₩5.4B | ₩11B |
| Borrowings | ₩0 | ₩1.8B |
| Total equity | ₩79B | ₩70B |
| Shareholders' equity | ₩79B | ₩70B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | −₩21B | −₩22B |
| Capital spending | −₩64M | −₩396M |
| Free cash flow | −₩21B | −₩22B |
Consolidated where available. Amounts in won.
Also known as: D&D Pharmatech / 디앤디파마텍 / 347850 / KRX:347850
Source: KRX statistical information